Br[C:2]1[CH:3]=[C:4]([CH:14]=[C:15]([O:19][CH3:20])[C:16]=1[O:17][CH3:18])[CH2:5][C:6]1[C:7]([NH2:13])=[N:8][C:9]([NH2:12])=[N:10][CH:11]=1.[Cl-].[Li+].C([C:27]1[C:32](O)=[C:31](C(C)(C)C)[CH:30]=[C:29](C)[CH:28]=1)(C)(C)C.N>O1CCOCC1>[CH3:20][O:19][C:15]1[CH:14]=[C:4]([CH2:5][C:6]2[C:7]([NH2:13])=[N:8][C:9]([NH2:12])=[N:10][CH:11]=2)[CH:3]=[C:2]([C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=2)[C:16]=1[O:17][CH3:18]138 mg of 5-(3-bromo-4,5-dimethoxy-benzyl)-pyrimidine-2,4-diamine, 98 mg of trimethyl-phenyl-stannate (Example 1a), 51 mg of lithium chloride, 25 mg of tetrakis-triphenylphosphinepalladium and a crystal of 2,6-di-t-butyl-p-cresol in 10 ml of dioxan are held at reflux under argon for 4 hrs. The yellowish reaction mixture is poured into about 10% aqueous ammonia and extracted three times with methylene chloride. The organic phase is dried over magnesium sulphate and chromatographed on silica gel with methylene chloride/methanol 9:1. 62 mg (46%) of 5-(5,6-dimethoxy-biphenyl-3-ylmethyl)-pyrimidine-2,4-diamine are isolated as a yellowish solid. Mass spectrum: peaks: inter alia at m/e: 336 (M+, 100%), 321 (28%), 305 (54%), 123 (36%).